Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arterial embolization by NK939 for hypervascular tumors and arteriovenous malformations
jRCT2080221247
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of NK939 in Neoplasm and arteriovenous malformation (AVM), sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
NK939
03
Conditions
Neoplasmarteriovenous malformation (AVM)
Beyond the preview
Go deeper on jRCT2080221247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221247.